The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
Vossen
C Y
CY
Rosendaal
F R
FR
D000293:Adolescent; D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D016022:Case-Control Studies; D003432:Cross-Linking Reagents / Q000494:pharmacology; D005176:Factor XIII / Q000235:genetics*; D005260:Female; D005340:Fibrinogen / Q000096:biosynthesis* / Q000378:metabolism; D005787:Gene Frequency; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007930:Leucine / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D009154:Mutation; D016017:Odds Ratio; D012306:Risk; D014633:Valine / Q000737:chemistry; D020246:Venous Thrombosis / Q000235:genetics* / Q000517:prevention & control*
D003432:Cross-Linking Reagents; D005340:Fibrinogen; D005176:Factor XIII; D007930:Leucine; D014633:Valine